Bayes Factor Group Sequential Designs
By: Samuel Pawel, Leonhard Held
Potential Business Impact:
Helps scientists stop experiments early with confidence.
The Bayes factor, the data-based updating factor from prior to posterior odds, is a principled measure of relative evidence for two competing hypotheses. It is naturally suited to sequential data analysis in settings such as clinical trials and animal experiments, where early stopping for efficacy or futility is desirable. However, designing such studies is challenging because computing design characteristics, such as the probability of obtaining conclusive evidence or the expected sample size, typically requires computationally intensive Monte Carlo simulations, as no closed-form or efficient numerical methods exist. To address this issue, we extend results from classical group sequential design theory to sequential Bayes factor designs. The key idea is to derive Bayes factor stopping regions in terms of the z-statistic and use the known distribution of the cumulative z-statistics to compute stopping probabilities through multivariate normal integration. The resulting method is fast, accurate, and simulation-free. We illustrate it with examples from clinical trials, animal experiments, and psychological studies. We also provide an open-source implementation in the bfpwr R package. Our method makes exploring sequential Bayes factor designs as straightforward as classical group sequential designs, enabling experiments to rapidly design informative and efficient experiments.
Similar Papers
The Bayesian optimal two-stage design for clinical phase II trials based on Bayes factors
Methodology
Tests new medicines faster and with fewer people.
Group Sequential Design with Posterior and Posterior Predictive Probabilities
Methodology
Helps tests finish faster or stop early.
Bayes Factor Hypothesis Testing in Meta-Analyses: Practical Advantages and Methodological Considerations
Methodology
Helps scientists combine study results to find truth.